4S

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) - The Lancet – 1994

Brief Summary:

In patients with prior MI or angina and hyperlipidemia, Simvastatin reduces all-cause mortality as well as CAD-related mortality.

Reference: http://www.ncbi.nlm.nih.gov/pubmed/7968073